Bailey Timothy C, Maruscak Adam A, Petersen Anne, White Sarah, Lewis James F, Veldhuizen Ruud A W
Lawson Health Research Institute, Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario N6A 4V2, Canada.
Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L703-9. doi: 10.1152/ajplung.00538.2005. Epub 2006 Apr 21.
Oxidative damage to surfactant can decrease lung function in vivo. In the current study, our two objectives were: 1) to examine whether the adverse effects of oxidized surfactant would be accentuated in animals exposed to high tidal volume ventilation, and 2) to test whether supplementation with surfactant protein A (SP-A) could improve the function of oxidized surfactant in vivo. The first objective was addressed by evaluating the response of surfactant-deficient rats administered normal or oxidized surfactant and then subjected to low tidal volume (6 ml/kg) or high tidal volume (12 ml/kg) mechanical ventilation. Under low tidal volume conditions, rats administered oxidized surfactant had impaired lung function, as determined by lung compliance and arterial blood gas analysis, compared with nonoxidized controls. Animals subjected to high tidal volume ventilation had impaired lung function compared with low tidal volume groups, regardless of the oxidative status of the surfactant. The second experiment demonstrated a significantly superior physiological response in surfactant-deficient rats receiving SP-A containing oxidized surfactant compared with oxidized surfactant. Lavage analysis at the end of the in vivo experimentation showed no differences in the recovery of oxidized surfactant compared with nonoxidized surfactant. We conclude that minimizing excessive lung stretch during mechanical ventilation is important in the context of exogenous surfactant supplementation and that SP-A has an important biophysical role in surfactant function in conditions of oxidative stress. Furthermore, the oxidative status of the surfactant does not appear to affect the alveolar metabolism of this material.
表面活性剂的氧化损伤可在体内降低肺功能。在本研究中,我们的两个目标是:1)研究在接受高潮气量通气的动物中,氧化表面活性剂的不良影响是否会加剧;2)测试补充表面活性剂蛋白A(SP-A)是否能在体内改善氧化表面活性剂的功能。第一个目标通过评估给予正常或氧化表面活性剂然后接受低潮气量(6 ml/kg)或高潮气量(12 ml/kg)机械通气的表面活性剂缺乏大鼠的反应来解决。在低潮气量条件下,与未氧化的对照组相比,给予氧化表面活性剂的大鼠肺功能受损,这通过肺顺应性和动脉血气分析确定。与低潮气量组相比,接受高潮气量通气的动物肺功能受损,无论表面活性剂的氧化状态如何。第二个实验表明,与氧化表面活性剂相比,接受含SP-A的氧化表面活性剂的表面活性剂缺乏大鼠的生理反应明显更好。体内实验结束时的灌洗分析表明,与未氧化的表面活性剂相比,氧化表面活性剂的回收没有差异。我们得出结论,在补充外源性表面活性剂的情况下,在机械通气期间尽量减少过度的肺扩张很重要,并且在氧化应激条件下,SP-A在表面活性剂功能中具有重要的生物物理作用。此外,表面活性剂的氧化状态似乎不影响该物质的肺泡代谢。